Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In vitro experiments showed that 10 ng/mL IGF-1 LR3 could increase the proliferation rate of breast cancer MCF-7 cells by three times, and reduce the sensitivity of chemotherapy drugs (such as paclitaxel) by 40%
By bypassing the digestive system, our IV therapy ensures that patients receive the full therapeutic benefit of these nutrients without any delays or losses
It provides enough of each component to begin experiencing effects while remaining conservative enough to assess tolerance
IGF-1 DES has an ultra-short half-life of about 20 to 30 minutes but approximately 10 times the potency at receptor sites compared to native IGF-1
Furthermore, the results suggest that the homocysteinylation might be regulated by the thiol redox status
US$ 29.50
US$ 28.75
US$ 27.99
US$ 25.47
